The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway

The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway

Abstract Background Lymphangiogenesis has been reported to play crucial roles in the metastasis of thyroid cancer (THCA), but despite the significant research on lymphangiogenesis in THCA, the precise regulatory mechanism remains unclear. Methods Public databases including the Cancer Genome Atlas (T...

Full description

Bibliographic Details
Main Authors: Liyun Yang, Runyu Zhao, Peipei Qiao, Jiaxin Cui, Xiaoping Chen, Jinping Fan, An Hu, Shuixian Huang
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Cancer Cell International
Subjects:
Thyroid cancer
Lymphangiogenesis
TET3
AHR
HIF-1α/VEGF signaling pathway
Online Access:https://doi.org/10.1186/s12935-023-03021-6

Internet

https://doi.org/10.1186/s12935-023-03021-6

Similar Items